Doctor profile · Federal record
Dr. David Mapes, PA-C
Physician Assistant · Fresno, CA
- NPI 1427428010
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2335 E Kashian Ln Ste 410
Fresno, CA 937012234
(559) 266-4100
fax (559) 266-4199 - Mailing address
-
2625 E Divisadero St
Fresno, CA 937211431
Credentials & registration
- NPI registered
- September 2015 — 11 yrs on file
- Profile last updated
- April 1, 2022
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- California #52822
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427428010. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
941
Distinct HCPCS
10
Medicare allowed
$56,807
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 225 | 153 | $79 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 144 | 36 | $6 | |
11102 |
Biopsy of related skin growth, first growth | 99 | 81 | $79 | |
17000 |
Destruction of precancer skin growth, 1 growth | 70 | 50 | $41 | |
17110 |
Destruction of skin growth, 1-14 growths | 67 | 51 | $102 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 65 | 65 | $98 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 65 | 43 | $112 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | 19 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 51 | 33 | $45 | |
11200 |
Removal of skin tag, 1-15 skin tags | 21 | 19 | $60 |
In context: peer comparison
Among 41 peers in Fresno Physician Assistant, average services per provider: 236. This provider delivers 4.0× the peer median.Open Payments
Industry payments received
All-time total
$1,301
Transactions
32
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 10 | $596.02 | |
| Janssen Biotech, INC. | 9 | $240.43 | |
| Novartis Pharmaceuticals Corporation | 2 | $193.65 | |
| Amgen INC. | 3 | $85.29 | |
| Genzyme Corporation | 1 | $37.68 | |
| Galderma Laboratories, L.P. | 1 | $30.19 | |
| Dermavant Sciences, INC. | 1 | $21.64 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $21.49 | |
| Verrica Pharmaceuticals INC. | 1 | $21.35 | |
| Incyte Corporation | 1 | $19.58 | |
| Lilly USA, LLC | 1 | $18.09 | |
| Smith+Nephew, INC. | 1 | $15.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
633
Patients
264
Total drug cost
$111,051
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 173 | 88 | $2,698 |
| Ketoconazole | Generic | 120 | 51 | $2,163 |
| Hydroxyzine Hcl | Generic | 54 | 24 | $651 |
| Clindamycin Phosphate | Generic | 47 | 19 | $1,505 |
| Clobetasol Propionate | Generic | 45 | 21 | $5,946 |
| Fluocinonide | Generic | 35 | 18 | $1,676 |
| Tretinoin | Generic | 29 | 0 | $3,887 |
| Doxycycline Hyclate | Generic | 26 | 16 | $603 |
| Dupixent Pen (Dupilumab) | Brand | 23 | 0 | $88,010 |
| Metronidazole | Generic | 23 | 0 | $2,263 |
Frequently asked questions
What is Dr. David Mapes's medical specialty?
Dr. David Mapes practices Physician Assistant in Fresno, CA.
Where does Dr. David Mapes practice?
Dr. David Mapes practices at 2335 E Kashian Ln Ste 410, Fresno, CA 937012234. Office phone: 5592664100.
What is Dr. David Mapes's NPI?
Dr. David Mapes's National Provider Identifier (NPI) is 1427428010, issued by NPPES.
Does Dr. David Mapes accept Medicare assignment?
Yes. Dr. David Mapes accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Mapes commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.